Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2023 Nov;24(7):660-665.
doi: 10.1016/j.cllc.2023.07.003. Epub 2023 Jul 19.

Tracking Clonal Evolution of EGFR-Mutated Non-Small Cell Lung Cancer Through Liquid Biopsy: Management of C797S Acquired Mutation

Alessandro Russo  1 , Katherine A Scilla  2 , Ranee Mehra  2 , Allison Gittens  2 , Michael G McCusker  3 , Diego de Miguel-Perez  4 , Jorge E Gomez  5 , Ariel Peleg  5 , Marzia Del Re  6 , Christian D Rolfo  7
Affiliations
Case Reports

Tracking Clonal Evolution of EGFR-Mutated Non-Small Cell Lung Cancer Through Liquid Biopsy: Management of C797S Acquired Mutation

Alessandro Russo et al. Clin Lung Cancer. 2023 Nov.
No abstract available

Keywords: Acquired resistance; Liquid biopsy; Osimertinib; Plasma NGS; Rechallenge.

PubMed Disclaimer

Conflict of interest statement

Disclosures Dr Russo has received advisory board honoraria from AstraZeneca, MSD, Novartis, Pfizer, Amgen, and BMS and writing engagement honoraria from AstraZeneca, MSD, Roche, and Novartis. Dr Rolfo has received speaker honoraria from AstraZeneca, Roche and MSD, advisory board honoraria from Inivata, Archer, Boston Pharmaceuticals, BMS, Pfizer, Mirati, Eisai, Daiichi Sankyo, Sanofi Genzyme-Regeneron, Blueprint, CEA. Bayer, General Dynamics, MedStar, Diverse HealthHub, MH Live Events, Janssen, Amgen, Lungevity, Imagene, ThermoFisher, Abbvie, MD Serono and Novartis, and institutional research funding for his work as Coordinating Principal Investigator from Pfizer and MD Serono and has performed nonrenumerated work on behalf of his institution for GuardantHealth. He has nonrenumerated leadership roles at the International Society of Liquid Biopsy (ISLB), the International Association for Study of Lung Cancer (IASLC), the European School of Oncology (ESO), and Oncology Latin American Association (OLA).

Publication types

MeSH terms